Pick Topic
Review Topic
List Experts
Examine Expert
Save Expert
  Site Guide ··   
Expertise in Melanoma: HELP
Sapna P. Patel
Based on 34 articles published since 2009
(Why 34 articles?)
||||
Expertise Level
The expertise of Sapna P. Patel ranks in the
  • Top 0.26%
  • ... of 106,334 published authors worldwide on Melanoma
  • ... from 2009 through 2019
  • ... based on contributions to 34 articles on the topic.
Graphical view (beta)
Get your prestigious
Expert badge
similar to this:
 
Aliases Patel, Sapna P   ·   Patel, Sapna
Work Locations
Details
Most likely:    University of Texas Houston   Contact    
2019
  • Department of Gastroenterology, Hepatology and Nutrition, The University of Texas, MD Anderson Cancer Center, Houston, TX, 77030, USA. · Department of Biostatistics, The University of Texas, MD Anderson Cancer Center, Houston, TX, 77030, USA. · Department of Nuclear Medicine, The University of Texas, MD Anderson Cancer Center, Houston, TX, 77030, USA. · Department of Melanoma Medical Oncology, The University of Texas, MD Anderson Cancer Center, Houston, TX, 77030, USA. · Department of Gastroenterology, Hepatology and Nutrition, The University of Texas, MD Anderson Cancer Center, Houston, TX, 77030, USA. · Pubmed 30666357
2018
  • Department of Melanoma Medical Oncology, MD Anderson Cancer Center, Houston, TX, USA. · Department of Breast Medical Oncology, MD Anderson Cancer Center, Houston, TX, USA. · Department of Surgical Oncology, MD Anderson Cancer Center, Houston, TX, USA. · Department of Head and Neck Surgery, MD Anderson Cancer Center, Houston, TX, USA. · Department of Immunology, MD Anderson Cancer Center, Houston, TX, USA. · Department of Biostatistics, MD Anderson Cancer Center, Houston, TX, USA. · Parker Institute for Cancer Immunotherapy, San Francisco, CA, USA. · Department of Genomic Medicine, MD Anderson Cancer Center, Houston, TX, USA. · Department of Pathology, MD Anderson Cancer Center, Houston, TX, USA. · Department of Genitourinary Cancers, MD Anderson Cancer Center, Houston, TX, USA. · Department of Translational and Molecular Pathology, MD Anderson Cancer Center, Houston, TX, USA. · Department of Surgical Oncology, MD Anderson Cancer Center, Houston, TX, USA. · Department of Genomic Medicine, MD Anderson Cancer Center, Houston, TX, USA. · Pubmed 30297909
  • Department of Melanoma Medical Oncology, The University of Texas MD Anderson Cancer Center, Houston, TX, USA. · Department of Surgical Oncology, The University of Texas MD Anderson Cancer Center, Houston, TX, USA. · Department of Pathology, The University of Texas MD Anderson Cancer Center, Houston, TX, USA. · Department of Genomic Medicine, The University of Texas MD Anderson Cancer Center, Houston, TX, USA. · Department of Biostatistics, The University of Texas MD Anderson Cancer Center, Houston, TX, USA. · Department of Surgical Oncology, The University of Texas MD Anderson Cancer Center, Houston, TX, USA; Department of Genomic Medicine, The University of Texas MD Anderson Cancer Center, Houston, TX, USA. · Department of Cancer Medicine, The University of Texas MD Anderson Cancer Center, Houston, TX, USA. · Department of Genitourinary Cancers, The University of Texas MD Anderson Cancer Center, Houston, TX, USA; Department of Immunology, The University of Texas MD Anderson Cancer Center, Houston, TX, USA. · Department of Immunology, The University of Texas MD Anderson Cancer Center, Houston, TX, USA. · Department of Surgical Oncology, The University of Texas MD Anderson Cancer Center, Houston, TX, USA; Department of Genomic Medicine, The University of Texas MD Anderson Cancer Center, Houston, TX, USA. Electronic address: · Pubmed 29361468
  • Georgina V. Long, University of Sydney, and Royal North Shore Hospital · Richard Kefford, Macquarie University, Sydney, and Westmead Hospital, Westmead, New South Wales · Jonathan Cebon, Ludwig Institute for Cancer Research, Melbourne, Victoria, Australia · Zeynep Eroglu, Moffitt Cancer Center, Tampa, FL · Jeffrey Infante, Tennessee Oncology · Douglas B. Johnson, Vanderbilt-Ingram Cancer Center, Nashville, TN · Sapna Patel, The University of Texas MD Anderson Cancer Center, Houston, TX · Adil Daud, University of California, San Francisco, San Francisco · Omid Hamid, The Angeles Clinic and Research Institute, Los Angeles, CA · Rene Gonzalez, University of Colorado, Denver, CO · Lynn Schuchter, University of Pennsylvania, Philadelphia, PA · William Sharfman, Sidney Kimmel Cancer Center, Baltimore, MD · Robert McWilliams, Mayo Clinic, Rochester, MN · Mario Sznol, Yale University, New Haven, CT · Suman Redhu, Eduard Gasal, and Bijoyesh Mookerjee, Novartis, East Hanover, NJ · Jeffrey Weber, New York University Langone Medical Center, New York, NY · and Keith T. Flaherty, Dana-Farber/Harvard Cancer Center, Boston, MA. · Pubmed 28991513
  • The University of Texas MD Anderson Cancer Center, Houston, TX, USA. · The University of Texas Health Science Center at Houston, Houston, TX, USA. · Corrona, LLC, Southborough, MA, USA. · The University of Texas MD Anderson Cancer Center, Houston, TX, USA; California Pacific Medical Center Research Institute, San Francisco, CA, USA. Electronic address: · Pubmed 30347335
  • Department of Breast Surgical Oncology, University of Texas MD Anderson Cancer Center, Houston, TX. · Department of Surgical Oncology, University of Texas MD Anderson Cancer Center, Houston, TX. · Department of Melanoma Medical Oncology, University of Texas MD Anderson Cancer Center, Houston, TX. · Department of Breast Surgical Oncology, University of Texas MD Anderson Cancer Center, Houston, TX; Department of Surgical Oncology, University of Texas MD Anderson Cancer Center, Houston, TX. Electronic address: · Pubmed 29746918
  • The University of Texas MD Anderson Cancer Center, 1515 Holcombe Blvd # 430, Houston, TX, 77030, USA. · The University of Texas Health Science Center, Houston, TX, USA. · The University of Texas MD Anderson Cancer Center, 1515 Holcombe Blvd # 430, Houston, TX, 77030, USA. · Pubmed 29704079
2017
  • Department of Melanoma Medical Oncology, The University of Texas MD Anderson Cancer Center, 1515 Holcombe Blvd, Houston, TX, 77030, USA. · Department of Melanoma Medical Oncology, The University of Texas MD Anderson Cancer Center, 1515 Holcombe Blvd, Houston, TX, 77030, USA. · Moffitt Cancer Center, 12902 USF Magnolia Dr., Tampa, FL, 33612, USA. · Department of Biostatistics, The University of Texas MD Anderson Cancer Center, 1515 Holcombe Blvd, Houston, TX, 77030, USA. · California Pacific Medical Center, 2323 Sacramento St. #2, San Francisco, CA, 94115, USA. · The University of Texas Banner MD Anderson Cancer Center, 2946 E Banner Gateway Dr., Gilbert, AZ, 85234, USA. · Pubmed 28612140
2016
  • Department of Melanoma Medical Oncology, The University of Texas MD Anderson Cancer Center, Houston, Texas. · Department of Hematology / Oncology, H. Lee Moffitt Cancer Center, Tampa, Florida. · Department of Head and Neck Surgery, Section of Ophthalmology, The University of Texas MD Anderson Cancer Center. · Department of Pathology, The University of Texas MD Anderson Cancer Center. · Department of Plastic Surgery, The University of Texas MD Anderson Cancer Center. · Department of Surgical Oncology, The University of Texas MD Anderson Cancer Center. · Department of Systems Biology, The University of Texas MD Anderson Cancer Center. · Pubmed 26991400
  • Department of Melanoma Medical Oncology, University of Texas MD Anderson Cancer Center, Houston. · Division of Cancer Medicine, University of Texas MD Anderson Cancer Center, Houston. · Beth Israel Deaconess Medical Center, Boston, Massachusetts. · Departments of Pathology and Translational and Molecular Pathology, University of Texas MD Anderson Cancer Center, Houston. · Broad Institute, Cambridge, Massachusetts. · Department of Surgical Oncology, University of Texas MD Anderson Cancer Center, Houston7Department of Genomic Medicine, University of Texas MD Anderson Cancer Center, Houston. · Department of Biostatistics, University of Texas MD Anderson Cancer Center, Houston. · Massachusetts General Hospital, Boston. · California Pacific Medical Center Research Institute, San Francisco. · Department of Melanoma Medical Oncology, University of Texas MD Anderson Cancer Center, Houston11Department of Systems Biology, University of Texas MD Anderson Cancer Center, Houston. · Pubmed 27124486
  • Department of Genomic Medicine, The University of Texas MD Anderson Cancer Center, Houston, Texas. Department of Pathology, The University of Texas MD Anderson Cancer Center, Houston, Texas. · Department of Genomic Medicine, The University of Texas MD Anderson Cancer Center, Houston, Texas. · Department of Surgical Oncology, The University of Texas MD Anderson Cancer Center, Houston, Texas. · Department of Genomic Medicine, The University of Texas MD Anderson Cancer Center, Houston, Texas. Department of Surgical Oncology, The University of Texas MD Anderson Cancer Center, Houston, Texas. · Department of Biostatistics, The University of Texas MD Anderson Cancer Center, Houston, Texas. · Department of Translational Molecular Pathology, The University of Texas MD Anderson Cancer Center, Houston, Texas. · Department of Cancer Medicine, The University of Texas MD Anderson Cancer Center, Houston, Texas. · Department of Pathology, The University of Texas MD Anderson Cancer Center, Houston, Texas. · Department of Melanoma Medical Oncology, The University of Texas MD Anderson Cancer Center, Houston, Texas. · Department of Pathology, The University of Texas MD Anderson Cancer Center, Houston, Texas. Department of Translational Molecular Pathology, The University of Texas MD Anderson Cancer Center, Houston, Texas. · Department of Immunology, The University of Texas MD Anderson Cancer Center, Houston, Texas. · Department of Lymphoma/Myeloma, The University of Texas MD Anderson Cancer Center, Houston, Texas. · Department of Microbiology and Immunobiology, Harvard Medical School, Boston, Massachusetts. · Department of Immunology, The University of Texas MD Anderson Cancer Center, Houston, Texas. Genitourinary Medical Oncology, The University of Texas MD Anderson Cancer Center, Houston, Texas. · Department of Genomic Medicine, The University of Texas MD Anderson Cancer Center, Houston, Texas. Department of Surgical Oncology, The University of Texas MD Anderson Cancer Center, Houston, Texas. · Pubmed 27301722
  • Department of Investigational Cancer Therapeutics (Phase I Clinical Trials Program), The University of Texas MD Anderson Cancer Center, Houston, Texas. · Department of Investigational Cancer Therapeutics (Phase I Clinical Trials Program), The University of Texas MD Anderson Cancer Center, Houston, Texas. · Biocartis, Mechelen, Belgium. · Department of Investigational Cancer Therapeutics (Phase I Clinical Trials Program), The University of Texas MD Anderson Cancer Center, Houston, Texas. Sarah Cannon Research Institute at HealthONE, Denver, Colorado. · Molecular Diagnostic Laboratory, The University of Texas MD Anderson Cancer Center, Houston, Texas. · Department of Gastrointestinal Medical Oncology, The University of Texas MD Anderson Cancer Center, Houston, Texas. · Department of Melanoma Medical Oncology, The University of Texas MD Anderson Cancer Center, Houston, Texas. · Biocartis, Mechelen, Belgium. Cartagenia, Leuven, Belgium. · Department of Systems Biology, The University of Texas MD Anderson Cancer Center, Houston, Texas. · Department of Investigational Cancer Therapeutics (Phase I Clinical Trials Program), The University of Texas MD Anderson Cancer Center, Houston, Texas. Moores Cancer Center, The University of California San Diego, La Jolla, California. · Pubmed 27207774
  • Department of Medicine, Division of Hematology/Oncology, Vanderbilt University Medical Center, Nashville, TN, USA. · Department of Melanoma Medical Oncology, MD Anderson Cancer Center, University of Texas, Houston, TX, USA. · Department of Systems Biology, MD Anderson Cancer Center, University of Texas, Houston, TX, USA. · Melanoma and Immunotherapeutics Service, Memorial Sloan Kettering Cancer Center, New York, NY, USA. · Department of Cutaneous Oncology, Moffitt Cancer Center, Tampa, FL, USA. · Department of Cancer Biology, Vanderbilt University Medical Center, Nashville, TN, USA. · School of Medicine, Vanderbilt University Medical Center, Nashville, TN, USA. · Pubmed 27089234
  • From the Department of Melanoma Medical Oncology, The University of Texas MD Anderson Cancer Center, Houston, TX. · Pubmed 26825879
2015
  • Department of Investigational Cancer Therapeutics (Phase I Clinical Trials Program), The University of Texas MD Anderson Cancer Center, Houston, TX 77030, USA. · Biocartis NV, 2800 Mechelen, Belgium. · Sarah Cannon Research Institute at HealthONE, Denver, CO 80218, USA. · Cartagenia, 3001 Leuven, Belgium. · HistoGeneX NV, 2600 Berchem, Belgium. · Department of Melanoma Medical Oncology, The University of Texas MD Anderson Cancer Center, Houston, TX 77030, USA. · Department of Gastrointestinal Medical Oncology, The University of Texas MD Anderson Cancer Center, Houston, TX 77030, USA. · Molecular Diagnostics Laboratory, The University of Texas MD Anderson Cancer Center, Houston, TX 77030, USA. · Department of Pathology, The University of Texas MD Anderson Cancer Center, Houston, TX 77030, USA. · Center for Personalized Cancer Therapy, Moores Cancer Center, The University of California San Diego, La Jolla, CA 92093, USA. · Pubmed 26330075
  • Melanoma Medical Oncology, The University of Texas MD Anderson Cancer Center, Houston, Texas. · Melanoma Medical Oncology, The University of Texas MD Anderson Cancer Center, Houston, Texas. · Immunology, The University of Texas MD Anderson Cancer Center, Houston, Texas. · Stem Cell Transplantation and Cellular Therapy, The University of Texas MD Anderson Cancer Center, Houston, Texas. · Pubmed 26216417
  • Department of Pathology, MD Anderson Cancer Center, The University of Texas, Houston, Texas, USA. · Department of Surgical Oncology, MD Anderson Cancer Center, The University of Texas, Houston, Texas, USA. · Department of Biostatistics, MD Anderson Cancer Center, The University of Texas, Houston, Texas, USA. · Department of Melanoma Medical Oncology, MD Anderson Cancer Center, The University of Texas, Houston, Texas, USA. · Department of Pathology, MD Anderson Cancer Center, The University of Texas, Houston, Texas, USA; Department of Dermatology, MD Anderson Cancer Center, The University of Texas, Houston, Texas, USA. · Department of Surgical Oncology, MD Anderson Cancer Center, The University of Texas, Houston, Texas, USA; Department of Cancer Biology, MD Anderson Cancer Center, The University of Texas, Houston, Texas, USA. · Department of Melanoma Medical Oncology, MD Anderson Cancer Center, The University of Texas, Houston, Texas, USA; Department of Systems Biology, MD Anderson Cancer Center, The University of Texas, Houston, Texas, USA. · Department of Hematopathology, MD Anderson Cancer Center, The University of Texas, Houston, Texas, USA. · Department of Systems Biology, MD Anderson Cancer Center, The University of Texas, Houston, Texas, USA. · Department of Experimental Therapeutics, MD Anderson Cancer Center, The University of Texas, Houston, Texas, USA. · Department of Surgical Oncology, MD Anderson Cancer Center, The University of Texas, Houston, Texas, USA; Department of Investigational Cancer Therapeutics, MD Anderson Cancer Center, The University of Texas, Houston, Texas, USA. · Department of Melanoma Medical Oncology, MD Anderson Cancer Center, The University of Texas, Houston, Texas, USA; Department of Systems Biology, MD Anderson Cancer Center, The University of Texas, Houston, Texas, USA. Electronic address: · Pubmed 25148578
2014
  • Department of Melanoma Medical Oncology, University of Texas MD Anderson Cancer Center, Houston, TX, USA. · Pubmed 25030020
  • Melanoma Medical Oncology, University of Texas MD Anderson Cancer Center, 1515 Holcombe Blvd, Unit 0430, Houston, TX 77030. Electronic address: · Pubmed 24694446
2013
  • Department of Melanoma Medical Oncology, The University of Texas M. D. Anderson Cancer Center, Houston, Texas, USA. · Pubmed 22972589
2012
  • The University of Texas MD Anderson Cancer Center, Houston, TX, USA. · Pubmed 22394161
2011
  • Melanoma Medical Oncology, Department, University of Texas, MD Anderson Cancer Center, Houston, TX 77054, USA. · Pubmed 22267918
  • Department of Melanoma Medical Oncology, The University of Texas M.D. Anderson Cancer Center, Houston, Texas 77030, USA. · Pubmed 21738104
2016
  • Departments of aMelanoma Medical Oncology bBiostatistics cSystems Biology, UT MD Anderson Cancer Center, Houston, Texas, USA. · Pubmed 27540836
2014
  • aHealth Science Center, University of Oklahoma, Oklahoma City, Oklahoma Departments of bMelanoma Medical Oncology cPalliative Care and Rehabilitative Medicine dBiostatistics, The University of Texas MD Anderson Cancer Center, Houston, Texas, USA. · Pubmed 24743052
2013
  • From the Ophthalmic Oncology Service, Memorial Sloan-Kettering Cancer Center, New York, NY; Melanoma Medical Oncology, University of Texas MD Anderson Cancer Center, Houston, TX; Section of Ophthalmology, University of Texas MD Anderson Cancer Center, Houston, TX; Melanoma and Sarcoma Service, Memorial Sloan-Kettering Cancer Center, New York, NY. · Pubmed 23714555
  • M.D. Anderson Cancer Center, University of Texas, Houston, TX 77054, USA. · Pubmed 23603862
  • Departments of *Melanoma Medical Oncology †Biostatistics, MD Anderson Cancer Center, The University of Texas, Houston, TX. · Pubmed 22706174
2012
  • Departments of Melanoma Medical Oncology, The University of Texas MD Anderson Cancer Center, Houston, Texas 77030, USA. · Pubmed 23032743
  • Department of Melanoma Medical Oncology, The University of Texas MD Anderson Cancer Center, Houston, TX 77030, USA. · Pubmed 22809251
  • Department of Melanoma Medical Oncology, University of Texas, MD Anderson Cancer Center, Houston, Texas 77054, USA. · Pubmed 22584956
2011
  • Department of Melanoma/Medical Oncology, The University of Texas M.D. Anderson Cancer Center, 1515 Holcombe Boulevard, Houston, TX 77030, USA. · Pubmed 21346640
Possible:    University of Oklahoma      
2014
  • aHealth Science Center, University of Oklahoma, Oklahoma City, Oklahoma Departments of bMelanoma Medical Oncology cPalliative Care and Rehabilitative Medicine dBiostatistics, The University of Texas MD Anderson Cancer Center, Houston, Texas, USA. · Pubmed 24743052
Possible:    Memorial Sloan-Kettering Cancer Center   Contact    
2013
  • From the Ophthalmic Oncology Service, Memorial Sloan-Kettering Cancer Center, New York, NY; Melanoma Medical Oncology, University of Texas MD Anderson Cancer Center, Houston, TX; Section of Ophthalmology, University of Texas MD Anderson Cancer Center, Houston, TX; Melanoma and Sarcoma Service, Memorial Sloan-Kettering Cancer Center, New York, NY. · Pubmed 23714555
Specific Interests

In the titles of their published articles, experts often reveal their very specific interests.

Here are the titles of the 10 most recent articles (out of 34 total) written by Sapna P. Patel about Melanoma:

  • Immune checkpoint inhibitor-induced colitis as a predictor of survival in metastatic melanoma. 2019
  • Neoadjuvant immune checkpoint blockade in high-risk resectable melanoma. 2018
  • Neoadjuvant plus adjuvant dabrafenib and trametinib versus standard of care in patients with high-risk, surgically resectable melanoma: a single-centre, open-label, randomised, phase 2 trial. 2018
  • Long-Term Outcomes in Patients With BRAF V600-Mutant Metastatic Melanoma Who Received Dabrafenib Combined With Trametinib. 2018
  • Association between melanoma and renal-cell carcinoma for sequential diagnoses: A single-center retrospective study. 2018
  • Case Report of Myeloid Sarcoma Masquerading as In-Transit Metastasis at a Previous Melanoma Site: Avoiding a Diagnostic Pitfall. 2018
  • Circulating Tumor Cells in Stage IV Melanoma Patients. 2018
  • Leptomeningeal disease in uveal melanoma: a case series. 2018
  • A phase II study of ipilimumab plus temozolomide in patients with metastatic melanoma. 2017
  • Uveal melanoma: From diagnosis to treatment and the science in between. 2016
Show List of Full Article Records
Google Searches

Learn more about Sapna P. Patel using the ready-made Google searches below.
This is essential! -- Publications never tell the whole story!

General Search:
University of Texas Houston
University of Oklahoma
Memorial Sloan-Kettering Cancer Center
Affiliation Timeline
Click for institutional directory in table below. (Not always available.)
What is this?
University of Texas Houston
2019
  • Department of Gastroenterology, Hepatology and Nutrition, The University of Texas, MD Anderson Cancer Center, Houston, TX, 77030, USA. · Department of Biostatistics, The University of Texas, MD Anderson Cancer Center, Houston, TX, 77030, USA. · Department of Nuclear Medicine, The University of Texas, MD Anderson Cancer Center, Houston, TX, 77030, USA. · Department of Melanoma Medical Oncology, The University of Texas, MD Anderson Cancer Center, Houston, TX, 77030, USA. · Department of Gastroenterology, Hepatology and Nutrition, The University of Texas, MD Anderson Cancer Center, Houston, TX, 77030, USA. · Pubmed 30666357
2018
  • Department of Melanoma Medical Oncology, MD Anderson Cancer Center, Houston, TX, USA. · Department of Breast Medical Oncology, MD Anderson Cancer Center, Houston, TX, USA. · Department of Surgical Oncology, MD Anderson Cancer Center, Houston, TX, USA. · Department of Head and Neck Surgery, MD Anderson Cancer Center, Houston, TX, USA. · Department of Immunology, MD Anderson Cancer Center, Houston, TX, USA. · Department of Biostatistics, MD Anderson Cancer Center, Houston, TX, USA. · Parker Institute for Cancer Immunotherapy, San Francisco, CA, USA. · Department of Genomic Medicine, MD Anderson Cancer Center, Houston, TX, USA. · Department of Pathology, MD Anderson Cancer Center, Houston, TX, USA. · Department of Genitourinary Cancers, MD Anderson Cancer Center, Houston, TX, USA. · Department of Translational and Molecular Pathology, MD Anderson Cancer Center, Houston, TX, USA. · Department of Surgical Oncology, MD Anderson Cancer Center, Houston, TX, USA. · Department of Genomic Medicine, MD Anderson Cancer Center, Houston, TX, USA. · Pubmed 30297909
  • Department of Melanoma Medical Oncology, The University of Texas MD Anderson Cancer Center, Houston, TX, USA. · Department of Surgical Oncology, The University of Texas MD Anderson Cancer Center, Houston, TX, USA. · Department of Pathology, The University of Texas MD Anderson Cancer Center, Houston, TX, USA. · Department of Genomic Medicine, The University of Texas MD Anderson Cancer Center, Houston, TX, USA. · Department of Biostatistics, The University of Texas MD Anderson Cancer Center, Houston, TX, USA. · Department of Surgical Oncology, The University of Texas MD Anderson Cancer Center, Houston, TX, USA; Department of Genomic Medicine, The University of Texas MD Anderson Cancer Center, Houston, TX, USA. · Department of Cancer Medicine, The University of Texas MD Anderson Cancer Center, Houston, TX, USA. · Department of Genitourinary Cancers, The University of Texas MD Anderson Cancer Center, Houston, TX, USA; Department of Immunology, The University of Texas MD Anderson Cancer Center, Houston, TX, USA. · Department of Immunology, The University of Texas MD Anderson Cancer Center, Houston, TX, USA. · Department of Surgical Oncology, The University of Texas MD Anderson Cancer Center, Houston, TX, USA; Department of Genomic Medicine, The University of Texas MD Anderson Cancer Center, Houston, TX, USA. Electronic address: · Pubmed 29361468
  • Georgina V. Long, University of Sydney, and Royal North Shore Hospital · Richard Kefford, Macquarie University, Sydney, and Westmead Hospital, Westmead, New South Wales · Jonathan Cebon, Ludwig Institute for Cancer Research, Melbourne, Victoria, Australia · Zeynep Eroglu, Moffitt Cancer Center, Tampa, FL · Jeffrey Infante, Tennessee Oncology · Douglas B. Johnson, Vanderbilt-Ingram Cancer Center, Nashville, TN · Sapna Patel, The University of Texas MD Anderson Cancer Center, Houston, TX · Adil Daud, University of California, San Francisco, San Francisco · Omid Hamid, The Angeles Clinic and Research Institute, Los Angeles, CA · Rene Gonzalez, University of Colorado, Denver, CO · Lynn Schuchter, University of Pennsylvania, Philadelphia, PA · William Sharfman, Sidney Kimmel Cancer Center, Baltimore, MD · Robert McWilliams, Mayo Clinic, Rochester, MN · Mario Sznol, Yale University, New Haven, CT · Suman Redhu, Eduard Gasal, and Bijoyesh Mookerjee, Novartis, East Hanover, NJ · Jeffrey Weber, New York University Langone Medical Center, New York, NY · and Keith T. Flaherty, Dana-Farber/Harvard Cancer Center, Boston, MA. · Pubmed 28991513
  • The University of Texas MD Anderson Cancer Center, Houston, TX, USA. · The University of Texas Health Science Center at Houston, Houston, TX, USA. · Corrona, LLC, Southborough, MA, USA. · The University of Texas MD Anderson Cancer Center, Houston, TX, USA; California Pacific Medical Center Research Institute, San Francisco, CA, USA. Electronic address: · Pubmed 30347335
  • Department of Breast Surgical Oncology, University of Texas MD Anderson Cancer Center, Houston, TX. · Department of Surgical Oncology, University of Texas MD Anderson Cancer Center, Houston, TX. · Department of Melanoma Medical Oncology, University of Texas MD Anderson Cancer Center, Houston, TX. · Department of Breast Surgical Oncology, University of Texas MD Anderson Cancer Center, Houston, TX; Department of Surgical Oncology, University of Texas MD Anderson Cancer Center, Houston, TX. Electronic address: · Pubmed 29746918
  • The University of Texas MD Anderson Cancer Center, 1515 Holcombe Blvd # 430, Houston, TX, 77030, USA. · The University of Texas Health Science Center, Houston, TX, USA. · The University of Texas MD Anderson Cancer Center, 1515 Holcombe Blvd # 430, Houston, TX, 77030, USA. · Pubmed 29704079
2017
  • Department of Melanoma Medical Oncology, The University of Texas MD Anderson Cancer Center, 1515 Holcombe Blvd, Houston, TX, 77030, USA. · Department of Melanoma Medical Oncology, The University of Texas MD Anderson Cancer Center, 1515 Holcombe Blvd, Houston, TX, 77030, USA. · Moffitt Cancer Center, 12902 USF Magnolia Dr., Tampa, FL, 33612, USA. · Department of Biostatistics, The University of Texas MD Anderson Cancer Center, 1515 Holcombe Blvd, Houston, TX, 77030, USA. · California Pacific Medical Center, 2323 Sacramento St. #2, San Francisco, CA, 94115, USA. · The University of Texas Banner MD Anderson Cancer Center, 2946 E Banner Gateway Dr., Gilbert, AZ, 85234, USA. · Pubmed 28612140
2016
  • Department of Melanoma Medical Oncology, The University of Texas MD Anderson Cancer Center, Houston, Texas. · Department of Hematology / Oncology, H. Lee Moffitt Cancer Center, Tampa, Florida. · Department of Head and Neck Surgery, Section of Ophthalmology, The University of Texas MD Anderson Cancer Center. · Department of Pathology, The University of Texas MD Anderson Cancer Center. · Department of Plastic Surgery, The University of Texas MD Anderson Cancer Center. · Department of Surgical Oncology, The University of Texas MD Anderson Cancer Center. · Department of Systems Biology, The University of Texas MD Anderson Cancer Center. · Pubmed 26991400
  • Department of Melanoma Medical Oncology, University of Texas MD Anderson Cancer Center, Houston. · Division of Cancer Medicine, University of Texas MD Anderson Cancer Center, Houston. · Beth Israel Deaconess Medical Center, Boston, Massachusetts. · Departments of Pathology and Translational and Molecular Pathology, University of Texas MD Anderson Cancer Center, Houston. · Broad Institute, Cambridge, Massachusetts. · Department of Surgical Oncology, University of Texas MD Anderson Cancer Center, Houston7Department of Genomic Medicine, University of Texas MD Anderson Cancer Center, Houston. · Department of Biostatistics, University of Texas MD Anderson Cancer Center, Houston. · Massachusetts General Hospital, Boston. · California Pacific Medical Center Research Institute, San Francisco. · Department of Melanoma Medical Oncology, University of Texas MD Anderson Cancer Center, Houston11Department of Systems Biology, University of Texas MD Anderson Cancer Center, Houston. · Pubmed 27124486
  • Department of Genomic Medicine, The University of Texas MD Anderson Cancer Center, Houston, Texas. Department of Pathology, The University of Texas MD Anderson Cancer Center, Houston, Texas. · Department of Genomic Medicine, The University of Texas MD Anderson Cancer Center, Houston, Texas. · Department of Surgical Oncology, The University of Texas MD Anderson Cancer Center, Houston, Texas. · Department of Genomic Medicine, The University of Texas MD Anderson Cancer Center, Houston, Texas. Department of Surgical Oncology, The University of Texas MD Anderson Cancer Center, Houston, Texas. · Department of Biostatistics, The University of Texas MD Anderson Cancer Center, Houston, Texas. · Department of Translational Molecular Pathology, The University of Texas MD Anderson Cancer Center, Houston, Texas. · Department of Cancer Medicine, The University of Texas MD Anderson Cancer Center, Houston, Texas. · Department of Pathology, The University of Texas MD Anderson Cancer Center, Houston, Texas. · Department of Melanoma Medical Oncology, The University of Texas MD Anderson Cancer Center, Houston, Texas. · Department of Pathology, The University of Texas MD Anderson Cancer Center, Houston, Texas. Department of Translational Molecular Pathology, The University of Texas MD Anderson Cancer Center, Houston, Texas. · Department of Immunology, The University of Texas MD Anderson Cancer Center, Houston, Texas. · Department of Lymphoma/Myeloma, The University of Texas MD Anderson Cancer Center, Houston, Texas. · Department of Microbiology and Immunobiology, Harvard Medical School, Boston, Massachusetts. · Department of Immunology, The University of Texas MD Anderson Cancer Center, Houston, Texas. Genitourinary Medical Oncology, The University of Texas MD Anderson Cancer Center, Houston, Texas. · Department of Genomic Medicine, The University of Texas MD Anderson Cancer Center, Houston, Texas. Department of Surgical Oncology, The University of Texas MD Anderson Cancer Center, Houston, Texas. · Pubmed 27301722
  • Department of Investigational Cancer Therapeutics (Phase I Clinical Trials Program), The University of Texas MD Anderson Cancer Center, Houston, Texas. · Department of Investigational Cancer Therapeutics (Phase I Clinical Trials Program), The University of Texas MD Anderson Cancer Center, Houston, Texas. · Biocartis, Mechelen, Belgium. · Department of Investigational Cancer Therapeutics (Phase I Clinical Trials Program), The University of Texas MD Anderson Cancer Center, Houston, Texas. Sarah Cannon Research Institute at HealthONE, Denver, Colorado. · Molecular Diagnostic Laboratory, The University of Texas MD Anderson Cancer Center, Houston, Texas. · Department of Gastrointestinal Medical Oncology, The University of Texas MD Anderson Cancer Center, Houston, Texas. · Department of Melanoma Medical Oncology, The University of Texas MD Anderson Cancer Center, Houston, Texas. · Biocartis, Mechelen, Belgium. Cartagenia, Leuven, Belgium. · Department of Systems Biology, The University of Texas MD Anderson Cancer Center, Houston, Texas. · Department of Investigational Cancer Therapeutics (Phase I Clinical Trials Program), The University of Texas MD Anderson Cancer Center, Houston, Texas. Moores Cancer Center, The University of California San Diego, La Jolla, California. · Pubmed 27207774
  • Department of Medicine, Division of Hematology/Oncology, Vanderbilt University Medical Center, Nashville, TN, USA. · Department of Melanoma Medical Oncology, MD Anderson Cancer Center, University of Texas, Houston, TX, USA. · Department of Systems Biology, MD Anderson Cancer Center, University of Texas, Houston, TX, USA. · Melanoma and Immunotherapeutics Service, Memorial Sloan Kettering Cancer Center, New York, NY, USA. · Department of Cutaneous Oncology, Moffitt Cancer Center, Tampa, FL, USA. · Department of Cancer Biology, Vanderbilt University Medical Center, Nashville, TN, USA. · School of Medicine, Vanderbilt University Medical Center, Nashville, TN, USA. · Pubmed 27089234
  • From the Department of Melanoma Medical Oncology, The University of Texas MD Anderson Cancer Center, Houston, TX. · Pubmed 26825879
2015
  • Department of Investigational Cancer Therapeutics (Phase I Clinical Trials Program), The University of Texas MD Anderson Cancer Center, Houston, TX 77030, USA. · Biocartis NV, 2800 Mechelen, Belgium. · Sarah Cannon Research Institute at HealthONE, Denver, CO 80218, USA. · Cartagenia, 3001 Leuven, Belgium. · HistoGeneX NV, 2600 Berchem, Belgium. · Department of Melanoma Medical Oncology, The University of Texas MD Anderson Cancer Center, Houston, TX 77030, USA. · Department of Gastrointestinal Medical Oncology, The University of Texas MD Anderson Cancer Center, Houston, TX 77030, USA. · Molecular Diagnostics Laboratory, The University of Texas MD Anderson Cancer Center, Houston, TX 77030, USA. · Department of Pathology, The University of Texas MD Anderson Cancer Center, Houston, TX 77030, USA. · Center for Personalized Cancer Therapy, Moores Cancer Center, The University of California San Diego, La Jolla, CA 92093, USA. · Pubmed 26330075
  • Melanoma Medical Oncology, The University of Texas MD Anderson Cancer Center, Houston, Texas. · Melanoma Medical Oncology, The University of Texas MD Anderson Cancer Center, Houston, Texas. · Immunology, The University of Texas MD Anderson Cancer Center, Houston, Texas. · Stem Cell Transplantation and Cellular Therapy, The University of Texas MD Anderson Cancer Center, Houston, Texas. · Pubmed 26216417
  • Department of Pathology, MD Anderson Cancer Center, The University of Texas, Houston, Texas, USA. · Department of Surgical Oncology, MD Anderson Cancer Center, The University of Texas, Houston, Texas, USA. · Department of Biostatistics, MD Anderson Cancer Center, The University of Texas, Houston, Texas, USA. · Department of Melanoma Medical Oncology, MD Anderson Cancer Center, The University of Texas, Houston, Texas, USA. · Department of Pathology, MD Anderson Cancer Center, The University of Texas, Houston, Texas, USA; Department of Dermatology, MD Anderson Cancer Center, The University of Texas, Houston, Texas, USA. · Department of Surgical Oncology, MD Anderson Cancer Center, The University of Texas, Houston, Texas, USA; Department of Cancer Biology, MD Anderson Cancer Center, The University of Texas, Houston, Texas, USA. · Department of Melanoma Medical Oncology, MD Anderson Cancer Center, The University of Texas, Houston, Texas, USA; Department of Systems Biology, MD Anderson Cancer Center, The University of Texas, Houston, Texas, USA. · Department of Hematopathology, MD Anderson Cancer Center, The University of Texas, Houston, Texas, USA. · Department of Systems Biology, MD Anderson Cancer Center, The University of Texas, Houston, Texas, USA. · Department of Experimental Therapeutics, MD Anderson Cancer Center, The University of Texas, Houston, Texas, USA. · Department of Surgical Oncology, MD Anderson Cancer Center, The University of Texas, Houston, Texas, USA; Department of Investigational Cancer Therapeutics, MD Anderson Cancer Center, The University of Texas, Houston, Texas, USA. · Department of Melanoma Medical Oncology, MD Anderson Cancer Center, The University of Texas, Houston, Texas, USA; Department of Systems Biology, MD Anderson Cancer Center, The University of Texas, Houston, Texas, USA. Electronic address: · Pubmed 25148578
2014
  • Department of Melanoma Medical Oncology, University of Texas MD Anderson Cancer Center, Houston, TX, USA. · Pubmed 25030020
  • Melanoma Medical Oncology, University of Texas MD Anderson Cancer Center, 1515 Holcombe Blvd, Unit 0430, Houston, TX 77030. Electronic address: · Pubmed 24694446
2013
  • Department of Melanoma Medical Oncology, The University of Texas M. D. Anderson Cancer Center, Houston, Texas, USA. · Pubmed 22972589
2012
  • The University of Texas MD Anderson Cancer Center, Houston, TX, USA. · Pubmed 22394161
2011
  • Melanoma Medical Oncology, Department, University of Texas, MD Anderson Cancer Center, Houston, TX 77054, USA. · Pubmed 22267918
  • Department of Melanoma Medical Oncology, The University of Texas M.D. Anderson Cancer Center, Houston, Texas 77030, USA. · Pubmed 21738104
2016
  • Departments of aMelanoma Medical Oncology bBiostatistics cSystems Biology, UT MD Anderson Cancer Center, Houston, Texas, USA. · Pubmed 27540836
2014
  • aHealth Science Center, University of Oklahoma, Oklahoma City, Oklahoma Departments of bMelanoma Medical Oncology cPalliative Care and Rehabilitative Medicine dBiostatistics, The University of Texas MD Anderson Cancer Center, Houston, Texas, USA. · Pubmed 24743052
2013
  • From the Ophthalmic Oncology Service, Memorial Sloan-Kettering Cancer Center, New York, NY; Melanoma Medical Oncology, University of Texas MD Anderson Cancer Center, Houston, TX; Section of Ophthalmology, University of Texas MD Anderson Cancer Center, Houston, TX; Melanoma and Sarcoma Service, Memorial Sloan-Kettering Cancer Center, New York, NY. · Pubmed 23714555
  • M.D. Anderson Cancer Center, University of Texas, Houston, TX 77054, USA. · Pubmed 23603862
  • Departments of *Melanoma Medical Oncology †Biostatistics, MD Anderson Cancer Center, The University of Texas, Houston, TX. · Pubmed 22706174
2012
  • Departments of Melanoma Medical Oncology, The University of Texas MD Anderson Cancer Center, Houston, Texas 77030, USA. · Pubmed 23032743
  • Department of Melanoma Medical Oncology, The University of Texas MD Anderson Cancer Center, Houston, TX 77030, USA. · Pubmed 22809251
  • Department of Melanoma Medical Oncology, University of Texas, MD Anderson Cancer Center, Houston, Texas 77054, USA. · Pubmed 22584956
2011
  • Department of Melanoma/Medical Oncology, The University of Texas M.D. Anderson Cancer Center, 1515 Holcombe Boulevard, Houston, TX 77030, USA. · Pubmed 21346640
Unspecified
2018
  • Departments of Pathology. · Dermatology. · Translational and Molecular Pathology. · Hematopathology. · Melanoma Medical Oncology. · Leukemia. · Surgical Oncology, and. · Cancer Biology, The University of Texas MD Anderson Cancer Center, Houston, TX. · Pubmed 29863571
University of Oklahoma
2014
  • aHealth Science Center, University of Oklahoma, Oklahoma City, Oklahoma Departments of bMelanoma Medical Oncology cPalliative Care and Rehabilitative Medicine dBiostatistics, The University of Texas MD Anderson Cancer Center, Houston, Texas, USA. · Pubmed 24743052
Memorial Sloan-Kettering Cancer Center
2013
  • From the Ophthalmic Oncology Service, Memorial Sloan-Kettering Cancer Center, New York, NY; Melanoma Medical Oncology, University of Texas MD Anderson Cancer Center, Houston, TX; Section of Ophthalmology, University of Texas MD Anderson Cancer Center, Houston, TX; Melanoma and Sarcoma Service, Memorial Sloan-Kettering Cancer Center, New York, NY. · Pubmed 23714555
Yearly article counts 17173354300
Remember this Person You can save this page -- like a bookmark -- so it's remembered for you on the Expertscape "Saved Pages" page, which is always easily available from the page-top menu bar throughout the site.